Asset Sale vs Stock Sale — Tax Math and Liability Trade-offs
Buyers want asset deals. Sellers (especially C-corps) want stock deals. The fight is real and worth real money.
The bottom line
If you're a C-corp owner, asset deal is brutal — double tax (corporate gain + dividend on distribution). If you're an S-corp or LLC, asset and stock are closer on tax. Buyers prefer asset deals for the depreciation step-up + ability to leave behind liabilities; sellers prefer stock for cleaner exit and (often) lower tax. Healthcare practices typically end up as asset deals due to licensing reasons; SaaS deals often go stock to keep the contract assignments intact.
Side-by-side comparison
| Aspect | Asset Sale | Stock Sale |
|---|---|---|
| Buyer's tax position | Step-up basis on acquired assets — depreciable over 5-15 years, real tax savings | No basis step-up — buyer inherits seller's historical depreciation schedule |
| Seller's tax (C-corp) | Double tax: corporate gain (~21%) + dividend tax on distribution (~20-24%) — effective 35-40%+ on gain | Single tax at long-term capital gains rates (~20-24%) |
| Seller's tax (S-corp / LLC) | Single pass-through tax; can use 338(h)(10) election to get stock-deal tax treatment with asset-deal mechanics for the buyer | Single pass-through tax at LTCG rates |
| Liability transfer | Most liabilities stay with seller (key reason buyers prefer asset) | ALL liabilities transfer — including unknown ones. Buyer requires extensive reps and warranties + escrow. |
| Contract assignment | Each contract assigned individually — customer/vendor consent often required | Contracts stay in the entity; no assignment needed (but change-of-control clauses may trigger) |
| Licensing / permits | Often must be re-applied for in buyer's name — can delay close 60-180 days for healthcare | Permits + licenses stay with the entity; smoother in regulated industries |
| When buyers WILL accept stock | Rarely — only when assets can't be transferred (long-tail contracts, specific licenses) | Usually preferred by buyer when there's significant goodwill they want to keep, or in highly-regulated industries |
Get a real number for your business
Three-field instant valuation range. Backed by 25,592 real M&A transactions. No signup.
Run a valuation →Other comparisons
- Business Broker vs M&A Advisor / Investment Banker
- SDE (Seller's Discretionary Earnings) vs EBITDA
- Earnout (Contingent Consideration) vs All-Cash at Close
- Private Equity (PE) Buyer vs Strategic Buyer (operating company)
- Letter of Intent (LOI) vs Purchase Agreement (APA / SPA)
- Quality of Earnings (QofE) vs Financial Audit
Based on standard M&A practice and 4 years of healthcare-services M&A advisory experience. Edge cases vary by deal - not legal or tax advice. Methodology